26.07.2013 Views

Untitled - D Ank Unlimited

Untitled - D Ank Unlimited

Untitled - D Ank Unlimited

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

plasmacyte 576 plasma pool<br />

Plasma cells.<br />

Electron micrograph of plasma cell. N = nucleus. M = mitochondria.<br />

G = Golgi apparatus. ER = endoplasmic reticulum.<br />

size. Mature plasma cells have abundant cytoplasm, which<br />

stains deep blue with Wright’s stain, and have an eccentrically<br />

located round or oval nucleus, usually surrounded by<br />

a well defined perinuclear clear zone. The nucleus contains<br />

coarse and clumped masses of chromatin, often arranged in a<br />

cartwheel fashion. The nuclei of normal, mature plasma cells<br />

have no nucleoli, but those of neoplastic plasma cells such as<br />

those seen in multiple myeloma have conspicuous nucleoli.<br />

The cytoplasm of normal plasma cells has a conspicuous Golgi<br />

complex and rough endoplasmic reticulum and frequently<br />

contains vacuoles. The nuclear to cytoplasmic ratio is 1:2.<br />

By electron microscopy, plasma cells show very abundant<br />

endoplasmic reticulum, indicating extensive and active protein<br />

synthesis. Plasma cells do not express surface immunoglobulin<br />

or complement receptors which distinguishes them from B<br />

lymphocytes. Plasma cells that are short-lived differentiate<br />

quickly without manifesting isotype switching or somatic<br />

hypermutation leading to the secretion of low affinity IgM<br />

antibodies. Plasma cells that are long-lived differentiate following<br />

isotype switching and somatic hypermutation, which leads<br />

to the secretion of high-affinity antibodies that have various<br />

effector functions.<br />

plasmacyte<br />

Plasma cell.<br />

plasmacytoid dendritic cells (PDCs)<br />

Cells with a dendritic-like appearance arising from interferon-synthesizing<br />

cells activated in culture by inflammatory<br />

cytokines and products of microbes.<br />

plasmacytoma<br />

A plasma cell neoplasm. Also termed myeloma or multiple<br />

myeloma. To induce an experimental plasmacytoma<br />

Bone marrow plasmacytoma with pure plasma cell infiltrate.<br />

in laboratory mice or rats, paraffin oil is injected into the<br />

peritoneum. Plasmacytomas may occur spontaneously.<br />

These tumors, composed of neoplastic plasma cells, synthesize<br />

and secrete monoclonal immunoglobulins, yielding a<br />

homogeneous product that forms a spike in electrophoretic<br />

analysis of the serum. Plasmacytomas were used extensively<br />

to generate monoclonal immunoglobulins prior to<br />

the development of B cell hybridoma technology to induce<br />

monoclonal antibody synthesis at will to multiple antigens.<br />

plasma half-life (T 1/2 )<br />

Determination of the catabolic rate of any component of the<br />

blood plasma. With respect to immunoglobulins, it is the<br />

time required for one half of the plasma immunoglobulins<br />

to be catabolized.<br />

plasma histamine<br />

Even though histamine released from basophils and mast<br />

cells is a critical step in immediate hypersensitivity reactions,<br />

plasma histamine levels are rarely determined due to<br />

the short half-life of histamine in plasma. Thus, mast cell<br />

tryptase and thromboxane A 2 are the preferred analytes due<br />

to their longer half-lives.<br />

plasmapheresis<br />

A technique in which blood is withdrawn from an individual,<br />

the desired constituent is separated by centrifugation,<br />

and the cells are reinjected into the patient; for example,<br />

plasma components may be removed from the circulation of<br />

an individual by this method. The technique is also useful<br />

to obtain large amounts of antibodies from the plasma of<br />

an experimental animal. Plasmapheresis is used therapeutically<br />

to rid the body of toxins or autoantibodies in the blood<br />

circulation. Blood taken from the patient is centrifuged, the<br />

cells are saved, and the plasma is removed. Cells are resuspended<br />

in albumin, fresh normal plasma, or albumin in<br />

saline and returned to the patient. The ill effects of a toxin<br />

or of an autoantibody may be reduced by 65% by removing<br />

approximately 2500 mL of plasma. Removal of twice<br />

this amount of plasma may diminish the level of a toxin or<br />

of an autoantibody by an additional 20%. This procedure<br />

has been used to treat patients with myasthenia gravis,<br />

Eaton–Lambert syndrome, Goodpasture’s syndrome, hyperviscosity<br />

syndrome, post-transfusion purpura, and acute<br />

Guillain–Barré syndrome.<br />

plasma pool<br />

The amount of plasma immunoglobulin per unit of body<br />

weight. This may be designated as milligrams of immunoglobulin<br />

per kilogram of body weight.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!